High-dose aciclovir in CMV infection prophylaxis after allogeneic HSCT: a single-center long-term experience.

Bone Marrow Transplant · 2023 · PMC10622319 · PMID 37612466

Europe PMC DOI

hedged sentence

0.0590

closest p · 1.2× alpha

0.0590

boldest claim

The sentences

borderline significancep = 0.059so close (0.05 < p ≤ 0.1)

In contrast to these results, the differences were not statistically significant between CMV R+/D+ and CMV R−/D+ ( p = 0.777) and with a borderline significance in CMV R−/D− ( p = 0.059) patients.

also in 7,017 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.